These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31541594)

  • 1. A new proprietary gel containing glabridin, andrographolide, and apolactoferrin improves the appearance of epidermal melasma in adult women: A 6-month pilot, uncontrolled open-label study.
    Cantelli M; Ferrillo M; Donnarumma M; Emanuele E; Fabbrocini G
    J Cosmet Dermatol; 2020 Jun; 19(6):1395-1398. PubMed ID: 31541594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
    Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P
    J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation.
    Cantelli M; Ferrillo M; Granger C; Fabbrocini G
    J Cosmet Dermatol; 2022 Apr; 21(4):1523-1532. PubMed ID: 34087055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
    Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
    Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cream of herbal mixture to improve melasma.
    Zhang Q; Tu Y; Gu H; Sun D; Wu W; Man MQ; Chen H; Liu H; Ma X; He L
    J Cosmet Dermatol; 2019 Dec; 18(6):1721-1728. PubMed ID: 30980618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.
    Ramírez SP; Carvajal AC; Salazar JC; Arroyave G; Flórez AM; Echeverry HF
    J Drugs Dermatol; 2013 Jun; 12(6):e106-10. PubMed ID: 23839199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
    Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
    J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Advanced, Physician-Strength Retinol Peel Improves Signs of Aging and Acne Across a Range of Skin Types Including Melasma and Skin of Color.
    Sadick N; Edison BL; John G; Bohnert KL; Green B
    J Drugs Dermatol; 2019 Sep; 18(9):918-923. PubMed ID: 31524348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
    Crocco EI; Veasey JV; Boin MF; Lellis RF; Alves RO
    Cutis; 2015 Nov; 96(5):337-42. PubMed ID: 26682557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and evaluation of pigment distribution and response to therapy in melasma using in vivo reflectance confocal microscopy: a preliminary study.
    Ardigo M; Cameli N; Berardesca E; Gonzalez S
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1296-303. PubMed ID: 20337829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution.
    Kang HY; Bahadoran P; Suzuki I; Zugaj D; Khemis A; Passeron T; Andres P; Ortonne JP
    Exp Dermatol; 2010 Aug; 19(8):e228-33. PubMed ID: 20497220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
    Farshi S; Mansouri P; Kasraee B
    J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel triple combination in treatment of melasma: Significant outcome with far less actives.
    Pekmezci E
    J Cosmet Dermatol; 2019 Dec; 18(6):1700-1704. PubMed ID: 30920111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
    Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L
    J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.